Loading clinical trials...
Loading clinical trials...
Conditions
Interventions
Trichostatin A
Locations
11
United States
Vanda Investigational Site
Washington D.C., District of Columbia, United States
Vanda Investigational Site
Lafayette, Indiana, United States
Vanda Investigational Site
Hackensack, New Jersey, United States
Vanda Investigational Site
Seattle, Washington, United States
Vanda Investigational Site
Biała Podlaska, Poland
Vanda Investigational Site
Katowice, Poland
Start Date
September 27, 2018
Primary Completion Date
December 1, 2027
Completion Date
December 1, 2027
Last Updated
March 16, 2026
Lead Sponsor
Vanda Pharmaceuticals
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions